InkVivo Overview
- Year Founded
-
2020
- Status
-
Private
- Employees
-
10
- Latest Deal Type
-
Seed
- Latest Deal Amount
-
$1.33M
- Investors
-
10
InkVivo General Information
Description
Developer of drug delivery systems designed for the localized and temporal release of various active ingredients, including small molecules, biologics, and micronutrients. The company's targeted and sustained release technology allows for more effective treatments with reduced dosing frequency and minimized side effects, enabling pharmaceutical, nutraceutical, and veterinary industries to regulate the release of ingredients.
Contact Information
Website
www.inkvivo.techCorporate Office
- Piazza Cioccaro 4
- 6900 Lugano
- Switzerland
Corporate Office
- Piazza Cioccaro 4
- 6900 Lugano
- Switzerland
InkVivo Timeline
InkVivo Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 9. Seed Round | 04-Jun-2025 | $1.33M | Completed | Generating Revenue | ||
| 8. Accelerator/Incubator | Completed | Generating Revenue | ||||
| 7. Accelerator/Incubator | Completed | Generating Revenue | ||||
| 6. Seed Round | 01-May-2024 | Completed | Generating Revenue | |||
| 5. Accelerator/Incubator | 01-Nov-2022 | Completed | Startup | |||
| 4. Grant | 27-Sep-2022 | Completed | Generating Revenue | |||
| 3. Accelerator/Incubator | 02-Dec-2021 | Completed | Startup | |||
| 2. Grant | 13-Nov-2021 | $27.3K | Completed | Startup | ||
| 1. Spin-Off | 01-Jan-2020 | Completed | Startup |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
InkVivo Patents
InkVivo Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026022379-A1 | Gastroretentive formulations | Pending | 26-Jul-2024 |
InkVivo Signals
InkVivo Investors (10)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Claves Investments | Corporation | Minority | ||
| Creadd Ventures | Venture Capital | Minority | ||
| TiVenture | Venture Capital | Minority | ||
| SICTIC | Accelerator/Incubator | Minority | ||
| USI Startup Centre | Accelerator/Incubator |
InkVivo FAQs
-
When was InkVivo founded?
InkVivo was founded in 2020.
-
Where is InkVivo headquartered?
InkVivo is headquartered in Lugano, Switzerland.
-
What is the size of InkVivo?
InkVivo has 10 total employees.
-
What industry is InkVivo in?
InkVivo’s primary industry is Drug Delivery.
-
Is InkVivo a private or public company?
InkVivo is a Private company.
-
What is InkVivo’s current revenue?
The current revenue for InkVivo is .
-
How much funding has InkVivo raised over time?
InkVivo has raised $1.41M.
-
Who are InkVivo’s investors?
Claves Investments, Creadd Ventures, TiVenture, SICTIC, and USI Startup Centre are 5 of 10 investors who have invested in InkVivo.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process